Skip to main content

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ)

SHZ Healthcare Drug Manufacturers - Specialty & GenericView data quality →
43.0Fair

ValueMarkers Composite Index

Top 11%#39,713 of 44,707
Overvalued

10922% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-4.22
Low Risk
Altman
4.35
Safe
DCF Value
$0
Overvalued
ROIC
1.6%
Low
P/E
373.6
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) — VMCI valuation read

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (000766.SZ) carries a VMCI composite of 43/100, 7 points below the Healthcare sector median of 50. Among mid-cap names, that gap places 000766.SZ in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The 000766.SZ insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads 000766.SZ trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.3x is the binding constraint on the bear case, the line to track on Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's next 10-Q.

000766.SZ rose 0.7% over the trailing 7 days, with a -8.4% read on a 30-day basis.

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers its products in the form of capsules, tablets, injections, liquids, etc. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. was founded in 1990 and is based in Tonghua, China.

CEO: Yufu Zhang1,532 employeesCNwww.thjm.cn

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 000766.SZ’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.